Home Equities Score Here is why InspireMD Inc (NSPR) Stock facing negativity since last week?

Here is why InspireMD Inc (NSPR) Stock facing negativity since last week?

InspireMD Inc. (NSPR) shares lost 4.65% on Friday. NSPR shares have declined 46.05% over the last 12 months, and they have moved down by -33.05% in the past week. Over the past three months, the stock has lost -37.40%, while over the past six months, it has added 27.25%.

Let’s have a look at its recent developments

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Major changes of NSPR common stock

On April 14, 2021, InspireMD, Inc. announced major changes for its common stock in a special meeting of the stockholders and performed a 1-for-15 reverse split of its common stock, effective as of April 26, 2021.

The NSPR stock will trade on the NYSE American on a split-adjusted basis from April 27, 2021. The reverse stock split will reduce the number of common stock shares.

Recent financial results

On March 09, 2021, InspireMD, Inc announced financial results for the fourth quarter and the year ended December 31, 2020.

Q4 2020 financial highlights

  • For Q42020, revenue was$158,000, compared to $1,013,000 during the three months ended December 31, 2019.
  • For the three months ended December 31, 2020, gross profit was a negative $390,000, compared to $259,000 during the same quarter in 2019.
  • Total operating expenses for the reported quarter were $3,328,000, compared to $2,765,000 for the same period in 2019.
  • NSPR financial expenses were $131,000 for Q4 2020 compared to $27,000 during the three months ended December 31, 2019.
  • NSPR suffered a net loss of $3,853,000, or $0.10 per basic and diluted share in Q4 2020 compared to a net loss of $2,557,000, or $0.57 per basic and diluted share, for the same period in 2019.

Full-year 2020 financial highlights

  • InspireMD revenue decreased to $2,485,000 for FY 2020, from $3,721,000 during the twelve months ended December 31, 2019.
  • For the twelve months ended December 31, 2020, gross profit was $83,000, compared to $756,000 for the prior year.
  • For FY 2020 total operating expenses were $10,463,000compared to $10,572,000 for the same period in 2019.
  • NSPR spent $160,000 in financial expenses in FY 2020 compared to $200,000 for the same period in 2019.
  • The company suffered a net loss of $10,544,000, or $0.46 per basic and diluted share in FY 2020, compared to a net loss of $10,040,000, or $4.80 per basic and diluted share, for the same period in 2019.
  • InspireMD had cash and cash equivalents of $12,645,000 at decemebt 31, 2020, compared to $5,514,000 as of December 31, 2019.

Conclusion

NSPR past performance is not satisfactory and the recent major changes to its common stock also impacting its stock price in the market. We can hope for a positive trend at the start of the new week which is very unlikely.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Amarin Corporation plc (NASDAQ: AMRN) stock plunged in the premarket trading session; here’s why

In the premarket trading session, Amarin Corporation plc (AMRN) stock had plunged by -4.56% to $4.4. AMRN stock closed previous session at $4.61 gaining...

Why Second Sight Medical Products, Inc. (EYES) stock is Popping High today?

Second Sight Medical Products, Inc. (EYES) stock announced two-year results of its Orion Study after which the EYES stock price happened to be green...

Luokung Technology Corp. (LKCO) Stock Undergoes Volatility as Appeal Over CCMC Designation is Underway

Luokung Technology Corp. (LKCO) stock prices were down by 6.40% as of the market closing on May 11th, 2021, bringing the price per share...

Vista Gold Corp. (VGZ) Stock Inches Higher After Promising Q1 2021 Financial Reports

Vista Gold Corp. (VGZ) stock prices were up by an incremental 1.82% as of the market closing on May 11th, 2021, bringing the price...

Array Technologies, Inc. (ARRY) Stock Prices Stay Stable Despite Troubling Q1 2021 Financial Reports

Array Technologies, Inc. (ARRY) stock prices were up by a marginal 0.28% as of the market closing on May 11th, 2021, bringing the price...

Lucira Health Inc. (NASDAQ:LHDX) stock rallied today in the current trading session; here’s why

In the current trading session at last check, Lucira Health Inc. (LHDX) shares had surged by 15.32% to the price of $5.87. LHDX's stock...

PaySign, Inc. (PAYS) Stock Down Following Disclosure of Troubling Q1 2021 Financial Reports

PaySign, Inc. (PAYS) stock prices were down 15.0568% early in the trading day on May 12th, 2021, bringing the price per share down to...

Comstock Mining Inc. (NASDAQ:LODE) stock plunged in the current trading session; here’s why

In the current trading session at the last check, Comstock Mining Inc. (LODE) stock had plunged -3.25% to trade at $3.21. LODE stock previously...

Related News

China Automotive Inc. (NASDAQ: CAAS) stock gains during current market. What is happening?

China Automotive Inc. (NASDAQ: CAAS) stock soars by 9.83% during current market trading after CAAS released its first-quarter 2021 financial results. China Automotive Systems...

Urban Tea Inc. (NASDAQ: MYT) stock fell during pre-market trading session. Here’s to know what has happened?

Urban Tea Inc. (NASDAQ: MYT) stock declined by 1.51% at last close whereas the MYT stock price gains by 5.1% in the pre-market trading...

Checkpoint Therapeutics, Inc. (CKPT) Stock Undergoes Volatility after Release of Q1 2021 Financial Reports

Checkpoint Therapeutics, Inc. (CKPT) stock prices were up 4.17% as of the market closing on May 11th, 2021, bringing the price per share up...

Obalon Therapeutics Inc. soared in the recent premarket trading session here’s why

In the premarket trading session, at last check, Obalon Therapeutics Inc. (OBLN) stock had surged by 6.48% to $3.12. OBLN stock previously closed session...

Aslan Pharmaceuticals Inc. (NASDAQ: ASLN) stock declines during pre-market. Here’s what’s happening?

Aslan Pharmaceuticals Inc. (NASDAQ: ASLN) stock plunged by 1.77% at last close while the ASLN stock price keeps falling by 6.12% in the pre-market...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.